Kevin C. Tang
2019
In 2019, Kevin C. Tang earned a total compensation of $1 as Chairman and Chief Executive Officer at Odonate Therapeutics, which was the same as previous year.
Compensation breakdown
| Salary | $1 |
|---|---|
| Total | $1 |
Tang received $1 in salary, accounting for 100% of the total pay in 2019.
Rankings
In 2019, Kevin C. Tang's compensation ranked 13,971st out of 13,971 executives tracked by ExecPay.
| Classification | Ranking | Percentile |
|---|---|---|
All | 13,971 out of 13,971 | 0th |
Division Manufacturing | 5,700 out of 5,701 | 0th |
Major group Chemicals And Allied Products | 2,200 out of 2,200 | 0th |
Industry group Drugs | 1,886 out of 1,886 | 0th |
Industry Pharmaceutical Preparations | 1,398 out of 1,398 | 0th |
Source: SEC filing on May 15, 2020.
Tang's colleagues
We found two more compensation records of executives who worked with Kevin C. Tang at Odonate Therapeutics in 2019.
News
Odonate Therapeutics Chief Medical Officer Joseph O'Connell's 2020 pay falls 31% to $1.4M
June 1, 2021
Odonate Therapeutics Chief Medical Officer Joseph O'Connell's 2019 pay jumps 37% to $2M
May 15, 2020
Odonate Therapeutics Chief Medical Officer Joseph O'Connell's 2018 pay jumps 465% to $1.4M
June 24, 2019